Literature DB >> 2968487

Glucocorticoid effects on the production and actions of immune cytokines.

P M Guyre1, M T Girard, P M Morganelli, P D Manganiello.   

Abstract

The immunosuppressive actions of glucocorticoids form the basis for their use in treatment of autoimmune diseases and prevention of allograft rejection. However, the mechanisms responsible for glucocorticoid-induced immunosuppression are still poorly understood. It is now clear that glucocorticoids do not inhibit all aspects of the immune response and, in some cases, may enhance certain functions of immune effector cells. One example is that of the dramatic increase induced by IFN-gamma in the number of IgG Fc receptors on human mononuclear phagocytes, which is enhanced rather than inhibited by glucocorticoids. An aspect of the immune response which appears to be consistently suppressed by glucocorticoids is the production of immune cytokines. Since these hormones appear to be essential mediators for a vigorous immune response, inhibition of their production may be an effective way for glucocorticoids to block the immune response.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2968487     DOI: 10.1016/0022-4731(88)90080-5

Source DB:  PubMed          Journal:  J Steroid Biochem        ISSN: 0022-4731            Impact factor:   4.292


  25 in total

Review 1.  Endogenous lipid mediators in the resolution of airway inflammation.

Authors:  O Haworth; B D Levy
Journal:  Eur Respir J       Date:  2007-11       Impact factor: 16.671

2.  Corticosteroid can alter antigen expression on alveolar macrophages.

Authors:  L Marianayagam; L W Poulter
Journal:  Clin Exp Immunol       Date:  1991-09       Impact factor: 4.330

3.  Biochemical characterization of a glucocorticoid-induced membrane protein (RM3/1) in human monocytes and its application as model system for ranking glucocorticoid potency.

Authors:  P Högger; U Erpenstein; P Rohdewald; C Sorg
Journal:  Pharm Res       Date:  1998-02       Impact factor: 4.200

4.  Characterization of a novel anti-inflammatory factor produced by RM3/1 macrophages derived from glucocorticoid treated human monocytes.

Authors:  W Hamann; A Flöter; W Schmutzler; G Zwadlo-Klarwasser
Journal:  Inflamm Res       Date:  1995-12       Impact factor: 4.575

5.  An example of using a decision making framework designed for non-medical prescribers as a method for enhancing prescribing safety for inhaled corticosteroids (ICS).

Authors:  Saja Almarshad
Journal:  Saudi Pharm J       Date:  2014-06-17       Impact factor: 4.330

6.  The modulation of B7.2 and B7.1 on B cells by immunosuppressive agents.

Authors:  O Jirapongsananuruk; D Y Leung
Journal:  Clin Exp Immunol       Date:  1999-10       Impact factor: 4.330

7.  Development of specific antibody and in vivo response to antigen in different rat strains: effect of dexamethasone and importance of endogenous corticosteroids.

Authors:  S H Peers; G S Duncan; R J Flower
Journal:  Agents Actions       Date:  1993-07

8.  Two-compartment basophil cell trafficking model for methylprednisolone pharmacodynamics.

Authors:  J A Wald; D E Salazar; H Y Chen; W J Jusko
Journal:  J Pharmacokinet Biopharm       Date:  1991-10

9.  The two-edged sword of large-dose steroids for spinal cord trauma.

Authors:  S Galandiuk; G Raque; S Appel; H C Polk
Journal:  Ann Surg       Date:  1993-10       Impact factor: 12.969

Review 10.  Fc gamma receptors in cancer and infectious disease.

Authors:  M W Fanger; D V Erbe
Journal:  Immunol Res       Date:  1992       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.